Literature DB >> 10678508

Occipital atrophy is associated with visual hallucinations in Alzheimer's disease.

S Holroyd1, M L Shepherd, J H Downs.   

Abstract

In this study of patients with Alzheimer's disease (AD), patients with visual hallucinations were compared with patients who did not have visual hallucinations to determine if selective occipital lobe atrophy is associated with visual hallucinations. Seven AD patients with visual hallucinations were matched by cognitive score to 7 AD patients without visual hallucinations and 3-D MRI images obtained. A ratio of measured occipital volumes to whole brain volumes was compared between the two groups. AD patients with visual hallucinations had a significantly smaller occipital/whole brain ratio than AD patients without visual hallucinations. These results suggest visual hallucinations in AD may be associated with neuropathology of the occipital lobe.

Entities:  

Mesh:

Year:  2000        PMID: 10678508     DOI: 10.1176/jnp.12.1.25

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  23 in total

Review 1.  Visual hallucinations and the Charles Bonnet syndrome.

Authors:  Dominic H Ffytche
Journal:  Curr Psychiatry Rep       Date:  2005-06       Impact factor: 5.285

Review 2.  Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease.

Authors:  Mohamad El Haj; Jean Roche; Renaud Jardri; Dimitrios Kapogiannis; Karim Gallouj; Pascal Antoine
Journal:  Neurosci Biobehav Rev       Date:  2017-02-21       Impact factor: 8.989

3.  Cognitive dysfunction and cerebral volumetric deficits in individuals with Alzheimer's disease, alcohol use disorder, and dual diagnosis.

Authors:  Simon Zhornitsky; Shefali Chaudhary; Thang M Le; Yu Chen; Sheng Zhang; Stéphane Potvin; Herta H Chao; Christopher H van Dyck; Chiang-Shan R Li
Journal:  Psychiatry Res Neuroimaging       Date:  2021-08-29       Impact factor: 2.376

Review 4.  Distinguishing Neuroimaging Features in Patients Presenting with Visual Hallucinations.

Authors:  T T Winton-Brown; A Ting; R Mocellin; M Walterfang; D Velakoulis; F Gaillard
Journal:  AJNR Am J Neuroradiol       Date:  2016-01-07       Impact factor: 3.825

5.  Neuropsychiatric symptoms and global functional impairment along the Alzheimer's continuum.

Authors:  Lauren P Wadsworth; Natacha Lorius; Nancy J Donovan; Joseph J Locascio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  Dement Geriatr Cogn Disord       Date:  2012-08-28       Impact factor: 2.959

6.  Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum.

Authors:  Nancy J Donovan; Lauren P Wadsworth; Natacha Lorius; Joseph J Locascio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling; Gad A Marshall
Journal:  Am J Geriatr Psychiatry       Date:  2013-07-24       Impact factor: 4.105

7.  CHIMERA: Clustering of Heterogeneous Disease Effects via Distribution Matching of Imaging Patterns.

Authors:  Aoyan Dong; Nicolas Honnorat; Bilwaj Gaonkar; Christos Davatzikos
Journal:  IEEE Trans Med Imaging       Date:  2015-10-06       Impact factor: 10.048

8.  Diagnostic Assessment in Primary Progressive Aphasia: An Illustrative Case Example.

Authors:  Eduardo Europa; Leonardo Iaccarino; David C Perry; Elizabeth Weis; Ariane E Welch; Gil D Rabinovici; Bruce L Miller; Maria Luisa Gorno-Tempini; Maya L Henry
Journal:  Am J Speech Lang Pathol       Date:  2020-09-10       Impact factor: 2.408

Review 9.  Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns.

Authors:  Yaojing Chen; Mingxi Dang; Zhanjun Zhang
Journal:  Mol Neurodegener       Date:  2021-06-07       Impact factor: 14.195

10.  Behavioral and psychological symptoms of dementia.

Authors:  J Cerejeira; L Lagarto; E B Mukaetova-Ladinska
Journal:  Front Neurol       Date:  2012-05-07       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.